Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database ; day:30 ; month:3 ; year:2021 ; pages:1-13
Drugs - real world outcomes ; (30.3.2021), 1-13
- Creator
-
Russom, Mulugeta
Fitsum, Yodit
Abraham, Abiel
Savage, Ruth L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-021-00240-z
- URN
-
urn:nbn:de:101:1-2021052522362334112207
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Russom, Mulugeta
- Fitsum, Yodit
- Abraham, Abiel
- Savage, Ruth L.
- SpringerLink (Online service)
Other Objects (12)
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database
Citation analysis of database publications
Omeprazole-associated rhabdomyolysis
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Diclofenac-Augentropfen
Rhabdomyolysis induced by nelarabine
Perspectives on Exertional Rhabdomyolysis
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Rewodina/Diclofenac: Suppositorien
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database
Citation analysis of database publications
Omeprazole-associated rhabdomyolysis
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Diclofenac-Augentropfen
Rhabdomyolysis induced by nelarabine
Perspectives on Exertional Rhabdomyolysis
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Rewodina/Diclofenac: Suppositorien
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database
Citation analysis of database publications
Omeprazole-associated rhabdomyolysis
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Diclofenac-Augentropfen
Rhabdomyolysis induced by nelarabine
Perspectives on Exertional Rhabdomyolysis
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology